Market revenue in 2024 | USD 14.8 million |
Market revenue in 2030 | USD 28.7 million |
Growth rate | 11.8% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Obsessive Compulsive Disorder (OCD) |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 81.76% in 2024. Horizon Databook has segmented the Sweden deep brain stimulation devices market based on pain management, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden deep brain stimulation devices market is mainly driven by growing geriatric population, which has led to increase in the incidence of PD and other neurological disorders. Moreover, presence of well-developed healthcare system is another major factor driving the Sweden market.
The Swedish Neuroscience Institute is constantly trying to develop advanced deep brain stimulation devices to address Alzheimer’s disease.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account